Literature DB >> 14154222

A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.

D P CHAN, J H HO, A W WOO.   

Abstract

Entities:  

Keywords:  ADENOCARCINOMA; BLADDER NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, EPIDERMOID; CERVIX NEOPLASMS; CHINA; FALLOPIAN TUBE NEOPLASMS; FLUOROURACIL; KIDNEY NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; OVARIAN NEOPLASMS; RECTAL NEOPLASMS; TOXICOLOGIC REPORT; UTERINE NEOPLASMS

Mesh：

Substances：

Year:  1964        PMID： 14154222      PMCID： PMC2071241          DOI： 10.1038/bjc.1964.10

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  An evaluation of 5-fluorouracil in malignant disease.

Authors:  A J WEISS; L G JACKSON; R CARABASI
Journal:  Ann Intern Med       Date:  1961-11       Impact factor: 25.391

2.  Five years clinical experience with 5-fluorouracil.

Authors:  F J ANSFIELD; J M SCHROEDER; A R CURRERI
Journal:  JAMA       Date:  1962-07-28       Impact factor: 56.272

3.  A clinical study of 5-fluorouracil.

Authors:  G L GOLD; T C HALL; B J SHNIDER; O SELAWRY; J COLSKY; A H OWENS; M M DEDERICK; J F HOLLAND; C O BRINDLEY; R JONES
Journal:  Cancer Res       Date:  1959-10       Impact factor: 12.701

4.  Chemotherapy of solid cancer arising from the gastro-intestinal tract.

Authors:  J D HURLEY; E H ELLISON
Journal:  Ann Surg       Date:  1960-10       Impact factor: 12.969

5.  Use of 5-fluorouracil in treatment of bladder carcinomas.

Authors:  T L DEREN; W L WILSON
Journal:  J Urol       Date:  1960-04       Impact factor: 7.450

6.  The role of 5-fluorouracil in malignant disease.

Authors:  B J KENNEDY; A THEOLOGIDES
Journal:  Ann Intern Med       Date:  1961-11       Impact factor: 25.391

7.  A method of selecting patients for cancer chemotherapy.

Authors:  J D HURLEY; D S TRUMP; T J FLATLEY; J D RIESCH
Journal:  Arch Surg       Date:  1961-10

8.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

9.  Clinical studies with 5-fluorouracil.

Authors:  A R CURRERI; F J ANSFIELD; F A McIVER; H A WAISMAN; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.